Evaluation of Plasma Concentration and Hepatotoxicity of Voriconazole in Pediatric Patients following Hematopoietic Stem Cell Transplantation
Background: Invasive fungal infection is one of the most important causes of morbidity and mortality in pediatric patients undergoing Hematopoietic stem cell transplantation (HSCT). Voriconazole as a broad-spectrum anti-fungal agent which has been used widely for prevention and treatment of invasive...
Main Authors: | Hamidreza Taghvaye Masoumi, Molouk Hadjibabaie, Morvarid Zarif-Yeganeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2017-09-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/116 |
Similar Items
-
Evaluation of Risk Factors for Hepatic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
by: Zahrasadat Mirmoezi, et al.
Published: (2017-09-01) -
Impact of CYP2C19 polymorphisms on serum concentration of voriconazole in iranian hematological patients
by: Sholeh Ebrahimpour, et al.
Published: (2017-01-01) -
Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
by: Gu L, et al.
Published: (2023-08-01) -
Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity
by: Serdar Şıvgın, et al.
Published: (2013-06-01) -
Evaluation of Febrile Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation
by: Shahideh Amini, et al.
Published: (2014-01-01)